David Dai Stock Analyst Profile - UBS Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    David Dai

    Stock Analyst at UBS

    (2.47)
    # 3213
    Out of 5,506 analysts
    31
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Consumer Cyclical
    Top Industries:
    Biotechnology Medical - Pharmaceuticals Medical - Devices

    22 Stocks

    Name Action PT Current % Upside Ratings Updated
    MRUS Merus
    Downgrades: Neutral
    72 97
    		94.29 2.87% 2 Sep 30, 2025
    TLX Telix Pharmaceutical...
    Maintains: Buy
    23 20
    		10.28 94.55% 1 Sep 23, 2025
    SNDX Syndax Pharmaceutica...
    Maintains: Buy
    37 35
    		15.6 124.36% 2 Jul 15, 2025
    NRIX Nurix Therapeutics
    Maintains: Buy
    30 26
    		9.38 177.19% 2 Jul 10, 2025
    SMMT Summit Therapeutics
    Initiates Coverage On: Buy
    30
    		21.43 39.99% 1 Jul 1, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    88 129
    		n/a n/a 2 Jun 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    17 2
    		2.34 -14.53% 2 May 16, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    30 24
    		5.9 306.78% 2 May 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    100 100
    		84.22 18.74% 2 Mar 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    27 14
    		9.57 46.29% 2 Mar 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Sell
    24
    		34.21 -29.85% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    20
    		3.66 446.45% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    69
    		24 187.5% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    50
    		27.64 80.9% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    60
    		39.82 50.68% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Feb 24, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    28
    		0.83 3273.49% 1 Mar 31, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    40
    		35.65 12.2% 1 Mar 16, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    40
    		1.78 2147.19% 1 Feb 4, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    50
    		2.13 2247.42% 1 Nov 18, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    41 52
    		35.4 46.89% 1 Mar 17, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    41
    		n/a n/a 1 Apr 25, 2017